Parallel Advisors LLC Has $3.83 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Parallel Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 42,574 shares of the exchange traded fund’s stock after buying an additional 1,568 shares during the period. Parallel Advisors LLC owned approximately 0.06% of SPDR S&P Biotech ETF worth $3,834,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $29,000. Golden State Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth $29,000. Avior Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares in the last quarter. Tidemark LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares in the last quarter. Finally, Bank of Jackson Hole Trust bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth $43,000.

SPDR S&P Biotech ETF Stock Up 1.3 %

Shares of XBI opened at $88.29 on Tuesday. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The business’s fifty day moving average is $89.98 and its 200 day moving average is $94.69. The stock has a market cap of $5.72 billion, a P/E ratio of 11.47 and a beta of 0.99.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.